Manufacturer of gene sequencers for scientific breakthroughs (no data-related services)
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND AS… |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
— | |
| 2024 | CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND AS… |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND AS… |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND AS… |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND AS… |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER A… | 5 | — |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 5 |
| Defense | 4 |